Antimicrobial resistance is among the most significant threats to public health and development, says WHO Recce Pharmaceuticals is tackling the global health problem of antibiotic-resistant superbugs ...

Mr Graham is the Chief Executive Officer of Recce Pharmaceuticals. He was formerly Executive Director and has extensive experience in marketing, business development and commercialisation of ...

Recce Pharmaceuticals is tackling the global health problem of antibiotic-resistant superbugs and emerging viral pathogens with its new class of synthetic anti-infectives. However, since the mid ...

topical applications of R327G, including Phase III clinical activities in Indonesia, and IND-enabling activitiesPro forma cash position of A$19.8 million SYDNEY, Aug. 06, 2024 (GLOBE NEWSWIRE) -- ...

The development and commercialisation of a drug discovery and development business commercialising new Classes of synthetic anti-infectives with spectrum activity designed to address the urgent ...